Research progress in the diagnosis and treatment of peripheral exudative hemorrhagic choroidal retinopathy
10.3760/cma.j.cn511434-20221207-00646
- VernacularTitle:外周渗出性出血性脉络膜视网膜病变诊断及治疗研究进展
- Author:
Zitong HE
1
;
Jinguo YU
Author Information
1. 天津医科大学总医院眼科，天津 300072
- Keywords:
Peripheral exudative hemorrhagic chorioretinopathy;
Choroidal melanoma;
Multimodal imaging;
Review
- From:
Chinese Journal of Ocular Fundus Diseases
2023;39(11):949-953
- CountryChina
- Language:Chinese
-
Abstract:
Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a peripheral retinal disease characterized by subretinal hemorrhage and/or subretinal pigment epithelial hemorrhage or exudation. It is often misdiagnosed as age-related macular degeneration, polypoidal chorioretinopathy or choroidal melanoma. With the development of multimodal imaging, PEHCR has different features under different examinations, such as B-scan ultrasound, fluorescein fundus angiography, optical coherence tomography and so on, which contributes to differention from other diseases. Clinical treatments for the disease include intravitreal injection of retinal photocoagulation therapy, anti-vascular endothelial growth factor, pars plana vitrectomyand so on, but there is still no universal consensus. In order to gain a deeper understanding of the clinical features, treatment options and prognosis of PEHCR, minimize missed diagnoses and misdiagnoses, and improve treatment efficiency, further research is required.
